Efficacy and Safety of Apremilast in Combination with NBUVB and NBUVB Alone in Vitiligo Patients
Clinical trial NCT06593197 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06593197
- Sponsor
- Dow University of Health Sciences
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2026-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.